Home›Companies›Biotech & Pharma›Aloe Therapeutics

Aloe Therapeutics Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 18, 2024·Suggest an edit

About Aloe Therapeutics

Aloe Therapeutics is a private company based in Darnestown, Maryland, incorporated in 2020 in Delaware. It has reported $100,000 raised in one offering on Form D since March 2024. Its chief executive is Martha Sklavos.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 4, 2024Mar 18, 2024$100,000fully sold1$100KDebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Aloe Therapeutics's Form D filed Mar 18, 2024.

MS
Martha Sklavos
Chief Executive Officer and director

Sources

  1. SECAloe Therapeutics Inc. filing history